Capital Fund Management (CFM)
ANIK icon

Capital Fund Management (CFM)’s Anika Therapeutics ANIK Stock Holding History

Capital Fund Management (CFM)’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-19,483
Closed -$802K – 1448
2015
Q1 		$802K Buy
19,483
+12,683
+187% +$513K 0.01% 858
2014
Q4 		$277K Buy
+6,800
New +$266K ﹤0.01% 1377
2014
Q3 		– Sell
-5,298
Closed -$245K – 1506
2014
Q2 		$245K Buy
+5,298
New +$236K ﹤0.01% 1512

Other funds holding ANIK

TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Capital Fund Management (CFM)'s ANIK Position: Q2 2015 in Review

Capital Fund Management (CFM) sold out of Anika Therapeutics (ANIK) in Q2 2015, closing a stake of 19,483 shares — an estimated $802K sold.

Capital Fund Management (CFM) first reported a position in ANIK in Q2 2014 and held it in 3 quarters. The position peaked at $802K in Q1 2015. 136 funds tracked by Wall St. Rank hold ANIK as of Q2 2015.

  • Capital Fund Management (CFM) reported no remaining Anika Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 19,483 Anika Therapeutics shares in Q2 2015, an estimated $802K.
  • Capital Fund Management (CFM) first reported a position in Anika Therapeutics in Q2 2014 and held it in 3 quarters.
  • Capital Fund Management (CFM)'s Anika Therapeutics position peaked at $802K in Q1 2015.
  • 136 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2015.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2015, filed 28 Jul 2015.